Corrigendum to "Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis" [EClinicalMedicine 55 (2022) 101795].

ABSTRACT: [This corrects the article DOI: 10.1016/j.eclinm.2023.101904.][This corrects the article DOI: 10.1016/j.eclinm.2022.101795.].

SUBMITTER: Fu Z 

PROVIDER: S-EPMC10030905 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature